Cite
Tsaur I, Thurn K, Juengel E, et al. Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients. Cent European J Urol. 2016;69(3):247-251doi: 10.5173/ceju.2016.820.
Tsaur, I., Thurn, K., Juengel, E., Oppermann, E., Nelson, K., Thomas, C., Bartsch, G., Oremek, G. M., Haferkamp, A., Rubenwolf, P., & Blaheta, R. A. (2016). Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients. Central European journal of urology, 69(3), 247-251. https://doi.org/10.5173/ceju.2016.820
Tsaur, Igor, et al. "Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients." Central European journal of urology vol. 69,3 (2016): 247-251. doi: https://doi.org/10.5173/ceju.2016.820
Tsaur I, Thurn K, Juengel E, Oppermann E, Nelson K, Thomas C, Bartsch G, Oremek GM, Haferkamp A, Rubenwolf P, Blaheta RA. Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients. Cent European J Urol. 2016;69(3):247-251. doi: 10.5173/ceju.2016.820. Epub 2016 Jun 30. PMID: 27729989; PMCID: PMC5057049.
Copy
Download .nbib